You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
19 November 2024
Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences
18 November 2024
Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama®
15 November 2024
Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA
13 November 2024
25
Nov 24
Analysts’ Conference
28
Press Release – quarterly statement (call-date Q3)
22 October 2024
Half-yearly financial statements 2024
29 April 2024
Annual financial statements 2023
30 August 2023
Half-yearly financial statements 2023
1 October 2024
Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
19 August 2024
13 June 2024
21 August 2023
23 September 2022
Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen
7 September 2022
